ATLANTA -- Flu vaccine manufacturers expected to make a record number of doses for the next flu season, despite concerns that demand may drop, as this year's vaccine was largely ineffective.
The five companies that make flu vaccine for the U.S. market planned to make at least 143 million doses for the season.
About 120 million doses were made for this year, which has been the worst in four years in terms of adults dying from flu and pneumonia.
The Centers for Disease Control and Prevention said the vaccine was only 44 percent effective.
Comment on this story.